Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.
Spleen cells from mice immunized with purified carcinoembryonic antigen (CEA), an important tumor marker of human carcinomas, were fused with the mouse myeloma cell line P3-NSI/1-Ag4. Out of the 400 hybrids obtained, 2 secreted antibodies reacting specifically with two different antigenic determinants present on CEA molecules. They were cloned and established as permanent hybridoma cell lines. These antibodies, which have relatively high-affinities and can be produced in unlimited amounts, will be useful both for the immunochemical characterization of CEA and as a standard reagent for the identification of this antigen in human tissues and body fluids.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000302:isolation & purification*; D000918:Antibody Specificity; D001666:Binding Sites, Antibody; D002272:Carcinoembryonic Antigen; D002999:Clone Cells / Q000276:immunology; D000939:Epitopes; D006822:Hybrid Cells / Q000276:immunology; D007126:Immunoglobulin Allotypes; D007074:Immunoglobulin G; D007700:Kinetics; D051379:Mice
D000912:Antibodies, Neoplasm; D002272:Carcinoembryonic Antigen; D000939:Epitopes; D007126:Immunoglobulin Allotypes; D007074:Immunoglobulin G